If you or a loved one have suffered vision loss, retina damage, pigmentary maculopathy, macular degeneration, macular dystrophy or other eye injury after taking Elmiron for interstitial cystitis (i.e., painful bladder syndrome), you may be entitled to recover compensation from an Elmiron lawsuit case or settlement claim.
A team of drug injury lawyers and class action lawyers is investigating potential lawsuit and settlement cases of individuals who claim to have been diagnosed with maculopathy, macular degeneration, macular dystrophy, or have suffered vision loss, blindness, retina damage or other eye injuries after taking Elmiron.
Elmiron (a/k/a pentosan polysulfate or PPS) is a prescription medication (a white opaque hard gelatin capsule imprinted “BNP7600” containing 100 mg pentosan polysulfate sodium) used to treat interstitial cystitis (a chronic condition causing bladder pressure, bladder pain and/or pelvic pain or discomfort). Interstitial cystitis is also described as painful bladder syndrome (PBS), bladder pain syndrome (BPS), or chronic pelvic pain.
Elmiron Vision Loss Lawsuit Cases
Elmiron lawsuit and settlement cases potentially being investigated include claims of individuals who took Elmiron to treat interstitial cystitis and suffered vision loss or other eye injury including, among others:
- Maculopathy
- Pigmentary maculopathy
- Retinal maculopathy
- Macular retinopathy
- Macular degeneration
- Degeneration of the macula
- Macular dystrophy
- Retinal damage
- Pattern dystrophy
- Vision loss
- Vision impairment
- Visual disturbances
- Blurred vision
- Blindness (unilateral or bilateral)
- Other vision issues
- Other eye injury lawsuit cases
Elmiron lawsuits filed in federal district courts have been consolidated and/or transferred into a multi district litigation or MDL, styled Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation, MDL Case No. 2973, U.S. District Court, District of New Jersey.
Elmiron Lawsuit & Settlement Updates
Recent updates about Elmiron lawsuits and settlements include:
- January 2024: As of January 2, 2024 there were more than 1,900 Elmiron lawsuit cases filed in the federal Elmiron MDL case.
Elmiron Eye Damage Injury Claims
Researchers have recently studied the potential link between Elmiron exposure and its effect on the retina and vision. According to the British Journal of Opthamology, a study found an association of macular disease with long-term use of pentosan polysulfate sodium. According to the American Academy of Opthamology, a study conducted by Kaiser Permanente found evidence linking the bladder medication Elmiron (pentosan polysulfate sodium) to retinal damage and eye conditions.
According to a study published in Retina (The Journal of Retinal and Vitreous Diseases), individuals with higher levels of exposure to Elmiron were more likely to report vision problems (such as difficulty reading small print) and have a diagnosis of pigmentary maculopathy and/or macular degeneration than those who did not use Elmiron.
If you or someone you love took Elmiron and were diagnosed with pigmentary maculopathy or have suffered from vision loss, retina damage or other eye conditions after taking Elmiron, you may be entitled to compensation from an Elmiron lawsuit or settlement. Contact a drug injury lawyer to request a free case review.
*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.
**The listing of a company or product (e.g., Elmiron) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.
***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.
Fill out the form on the right for a free attorney review.